Skip to main content
Top
Published in: Medical Oncology 1/2013

01-03-2013 | Short Communication

Liposomal amphotericin B and surgery as successful therapy for pulmonary Lichtheimia corymbifera zygomycosis in a pediatric patient with acute promyelocytic leukemia on antifungal prophylaxis with posaconazole

Authors: Grazina Kleinotiene, Gintas Posiunas, Juozas Raistenskis, Edvardas Zurauskas, Sigita Stankeviciene, Valentina Daugelaviciene, Maciej Machaczka

Published in: Medical Oncology | Issue 1/2013

Login to get access

Abstract

Pulmonary zygomycosis, also referred to as mucormycosis, is a fungal infection of lungs caused by fungi of the order Mucorales in the class of Zygomycetes. It is usually associated with high morbidity and mortality. Here, we report the case of a 14-year-old girl with pediatric acute promyelocytic leukemia (APL) on antifungal prophylaxis with posaconazole, who developed pulmonary Lichtheimia corymbifera (formerly Absidia corymbifera) zygomycosis. She was successfully treated by means of liposomal amphotericin B (L-AmB) and surgery. To our knowledge, this is the first published report on pediatric APL and pulmonary zygomycosis in the English language literature. At present, the patient is in complete remission of her APL and without any signs of recurrence of zygomycosis. This report suggests that efficient diagnostics, increased physician awareness, and reliance on adjunctive surgical therapy can result in a favorable outcome of pulmonary zygomycosis in immunocompromised children with hematological malignancies.
Literature
1.
go back to reference Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010;36:1–53.PubMedCrossRef Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010;36:1–53.PubMedCrossRef
2.
go back to reference Björkholm M, Runarsson G, Celsing F, Kalin M, Petrini B, Engervall P. Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia. Scand J Infect Dis. 2001;33:316–9.PubMedCrossRef Björkholm M, Runarsson G, Celsing F, Kalin M, Petrini B, Engervall P. Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia. Scand J Infect Dis. 2001;33:316–9.PubMedCrossRef
3.
go back to reference Antoniadou A. Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect. 2009;15(Suppl 5):55–9.PubMedCrossRef Antoniadou A. Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect. 2009;15(Suppl 5):55–9.PubMedCrossRef
4.
go back to reference Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.PubMedCrossRef Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.PubMedCrossRef
5.
go back to reference Anderson ML. Infectious causes of bovine abortion during mid- to late-gestation. Theriogenology. 2007;68:474–86.PubMedCrossRef Anderson ML. Infectious causes of bovine abortion during mid- to late-gestation. Theriogenology. 2007;68:474–86.PubMedCrossRef
6.
go back to reference Piancastelli C, Ghidini F, Donofrio G, et al. Isolation and characterization of a strain of Lichtheimia corymbifera (ex Absidia corymbifera) from a case of bovine abortion. Reprod Biol Endocrinol. 2009;7:138.PubMedCrossRef Piancastelli C, Ghidini F, Donofrio G, et al. Isolation and characterization of a strain of Lichtheimia corymbifera (ex Absidia corymbifera) from a case of bovine abortion. Reprod Biol Endocrinol. 2009;7:138.PubMedCrossRef
7.
go back to reference Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma. 2004;45:1351–60.PubMedCrossRef Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma. 2004;45:1351–60.PubMedCrossRef
8.
go back to reference Liu ZH, Lv GX, Chen J, et al. Primary cutaneous zygomycosis due to Absidia corymbifera in a patient with cutaneous T cell lymphoma. Med Mycol. 2009;47:663–8.PubMedCrossRef Liu ZH, Lv GX, Chen J, et al. Primary cutaneous zygomycosis due to Absidia corymbifera in a patient with cutaneous T cell lymphoma. Med Mycol. 2009;47:663–8.PubMedCrossRef
9.
go back to reference Horré R, Jovanic B, Herff S, et al. Wound infection due to Absidia corymbifera and Candida albicans with fatal outcome. Med Mycol. 2004;42:373–8.PubMedCrossRef Horré R, Jovanic B, Herff S, et al. Wound infection due to Absidia corymbifera and Candida albicans with fatal outcome. Med Mycol. 2004;42:373–8.PubMedCrossRef
10.
go back to reference Mohammed S, Sahoo TP, Jayshree RS, et al. Sino-oral zygomycosis due to Absidia corymbifera in a patient with acute leukemia. Med Mycol. 2004;42:475–8.PubMedCrossRef Mohammed S, Sahoo TP, Jayshree RS, et al. Sino-oral zygomycosis due to Absidia corymbifera in a patient with acute leukemia. Med Mycol. 2004;42:475–8.PubMedCrossRef
11.
go back to reference Hopwood V, Hicks DA, Thomas S, Evans EGV. Primary cutaneous zygomycosis due to Absidia corymbifera in a patient with AIDS. J Med Vet Mycol. 1992;30:399–402.PubMedCrossRef Hopwood V, Hicks DA, Thomas S, Evans EGV. Primary cutaneous zygomycosis due to Absidia corymbifera in a patient with AIDS. J Med Vet Mycol. 1992;30:399–402.PubMedCrossRef
12.
go back to reference Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007;45:321–46.PubMedCrossRef Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007;45:321–46.PubMedCrossRef
13.
go back to reference Torres-Narbona M, Guinea J, Martinez-Alarcon J, et al. Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol. 2007;45:2051–3.PubMedCrossRef Torres-Narbona M, Guinea J, Martinez-Alarcon J, et al. Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol. 2007;45:2051–3.PubMedCrossRef
14.
go back to reference Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992–1993: results of population-based laboratory active surveillance. Clin Infect Dis. 1998;27:1138–47.PubMedCrossRef Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992–1993: results of population-based laboratory active surveillance. Clin Infect Dis. 1998;27:1138–47.PubMedCrossRef
15.
go back to reference Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European confederation of medical mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859–67.PubMedCrossRef Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European confederation of medical mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859–67.PubMedCrossRef
16.
go back to reference Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the retrozygo study (2005–2007). Clin Infect Dis. 2012;54(Suppl 1):S35–43.PubMedCrossRef Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the retrozygo study (2005–2007). Clin Infect Dis. 2012;54(Suppl 1):S35–43.PubMedCrossRef
17.
go back to reference Zaoutis TE, Roilides E, Chiou CC, et al. Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis. 2007;26:723–7.CrossRef Zaoutis TE, Roilides E, Chiou CC, et al. Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis. 2007;26:723–7.CrossRef
18.
go back to reference Dehority W, Willert J, Pong A. Zygomycetes infections in pediatric hematology oncology patients: a case series and review of the literature. J Pediatr Hematol Oncol. 2009;31:911–9.PubMedCrossRef Dehority W, Willert J, Pong A. Zygomycetes infections in pediatric hematology oncology patients: a case series and review of the literature. J Pediatr Hematol Oncol. 2009;31:911–9.PubMedCrossRef
19.
go back to reference Giacchino M, Milano GM, Carraro F, et al. Current evidence of antifungal prophylaxis and therapy in pediatric patients. Pediatr Rep. 2011;3:e6.PubMedCrossRef Giacchino M, Milano GM, Carraro F, et al. Current evidence of antifungal prophylaxis and therapy in pediatric patients. Pediatr Rep. 2011;3:e6.PubMedCrossRef
20.
go back to reference O’Brien D, Lim CH, Farrell M, et al. Invasive intracerebral fungal infection in a leukaemic patient. Br J Neurosurg. 2012;26:423–5.PubMedCrossRef O’Brien D, Lim CH, Farrell M, et al. Invasive intracerebral fungal infection in a leukaemic patient. Br J Neurosurg. 2012;26:423–5.PubMedCrossRef
21.
go back to reference Mantadakis E, Samonis G, Kalmanti M. A comprehensive review of acute promyelocytic leukemia in children. Acta Haematol. 2008;119:73–82.PubMedCrossRef Mantadakis E, Samonis G, Kalmanti M. A comprehensive review of acute promyelocytic leukemia in children. Acta Haematol. 2008;119:73–82.PubMedCrossRef
22.
go back to reference Bally C, Fadlallah J, Leverger G, et al. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL group. J Clin Oncol. 2012;30:1641–6.PubMedCrossRef Bally C, Fadlallah J, Leverger G, et al. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL group. J Clin Oncol. 2012;30:1641–6.PubMedCrossRef
23.
go back to reference Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med. 2004;350:950–2.PubMedCrossRef Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med. 2004;350:950–2.PubMedCrossRef
24.
go back to reference Trifilio SM, Bennett CL, Yarnold PR, et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007;39:425–9.PubMedCrossRef Trifilio SM, Bennett CL, Yarnold PR, et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007;39:425–9.PubMedCrossRef
25.
go back to reference Schalk E, Mohren M, Jentsch-Ullrich K, et al. Zygomycoses in patients with acute leukaemia. Ann Hematol. 2006;85:327–32.PubMedCrossRef Schalk E, Mohren M, Jentsch-Ullrich K, et al. Zygomycoses in patients with acute leukaemia. Ann Hematol. 2006;85:327–32.PubMedCrossRef
26.
go back to reference Herbrecht R. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. Int J Clin Pract. 2004;58:612–24.PubMedCrossRef Herbrecht R. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. Int J Clin Pract. 2004;58:612–24.PubMedCrossRef
27.
go back to reference Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother. 2002;46:2310–2.PubMedCrossRef Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother. 2002;46:2310–2.PubMedCrossRef
28.
go back to reference Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006;50:126–33.PubMedCrossRef Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006;50:126–33.PubMedCrossRef
Metadata
Title
Liposomal amphotericin B and surgery as successful therapy for pulmonary Lichtheimia corymbifera zygomycosis in a pediatric patient with acute promyelocytic leukemia on antifungal prophylaxis with posaconazole
Authors
Grazina Kleinotiene
Gintas Posiunas
Juozas Raistenskis
Edvardas Zurauskas
Sigita Stankeviciene
Valentina Daugelaviciene
Maciej Machaczka
Publication date
01-03-2013
Publisher
Springer US
Published in
Medical Oncology / Issue 1/2013
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-012-0433-3

Other articles of this Issue 1/2013

Medical Oncology 1/2013 Go to the issue